Robust Diagnostics, LLC provides multiplex antibody assay development services using microarray technology to measure 50 to 250 antibody-epitope and antibody-antigen interactions from < 10 uL of sample. We work with our customers to design assays and deliver the data to accelerate your pre-clinical projects.